Ticker Details
Cel-Sci Corporation CEL-SCI Corp is a biotechnology company. It is engaged in the research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system.
IPO Date:	December 1, 1984
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$24.98M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.20 | 6.04%
Avg Daily Range (30 D):	$0.06 | 4.68%
Avg Daily Range (90 D):	$0.11 | 6.30%

Institutional Daily Volume
Avg Daily Volume:	.88M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.4M

Trade Size
Avg Trade Size (Sh.):	474
Avg Trade Size (Sh.) (30 D):	209
Avg Trade Size (Sh.) (90 D):	230

Institutional Trades
Total Institutional Trades:	352
Avg Institutional Trade:	$1.44M
Avg Institutional Trade (30 D):	$.58M
Avg Institutional Trade (90 D):	$.58M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.59M
Avg Closing Trade (30 D):	$1.32M
Avg Closing Trade (90 D):	$1.32M
Avg Closing Volume:	5.66K

News

Nov 4, 2024 @ 8:52 PM 3 Interesting Emerging Growth Stock Ideas From the... Source: Professor Ari Zoldan

Dec 4, 2023 @ 6:10 PM Why U Power Shares Are Trading Lower By Around 54%... Source: Lisa Levin

Jul 18, 2023 @ 5:00 PM Why Lixte Biotechnology Shares Are Trading Lower B... Source: Lisa Levin

Jul 18, 2023 @ 1:51 PM US Stocks Mixed; Bank of America Tops Q2 Views Source: Lisa Levin

Jul 18, 2023 @ 12:12 PM Why Biophytis Shares Are Trading Higher By 54%; He... Source: Lisa Levin

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS
Diluted EPS	$-1.69	$-.47	$-.67
Revenue	$-.44M	$-.11M	$-.12M
Gross Profit
Net Income / Loss	$22.7M	$5.67M	$5.47M
Operating Income / Loss	$-22.29M	$-5.56M	$-5.33M
Cost of Revenue
Net Cash Flow	$9.16M	$M	$M
PE Ratio

Splits
May 20, 2025	1:30
Jun 15, 2017	1:25
Sep 25, 2013	1:10